Neuroleptic malignant syndrome following administration of risperidone and lithium

J Clin Psychopharmacol. 2003 Jun;23(3):315-7. doi: 10.1097/00004714-200306000-00015.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Humans
  • Lithium Chloride / administration & dosage
  • Lithium Chloride / adverse effects*
  • Male
  • Neuroleptic Malignant Syndrome / diagnosis
  • Neuroleptic Malignant Syndrome / etiology*
  • Neuroleptic Malignant Syndrome / psychology
  • Risperidone / administration & dosage
  • Risperidone / adverse effects*

Substances

  • Lithium Chloride
  • Risperidone